Abstract: The invention relates to an ultrasonic sensor (112) for use in a distance detection system (110) for a vehicle (111), wherein the ultrasonic sensor (112) is designed to be installed jointly with at least one other ultrasonic sensor (112), the ultrasonic sensor (112) has a first input (114) for connection to a supply lead (116), the ultrasonic sensor (112) has a second input (118) for connection to a ground potential (120) of the vehicle (111), and the ultrasonic sensor (112) has an output (122) for connection to the supply lead (116), wherein the ultrasonic sensor (112) is designed to receive a data signal modulated on the supply lead (116) via the first input (114) and to modulate a data signal onto the supply lead (116) via the output (122).

Abstract: The disclosure relates to a diffusor for a gas generator of an airbag module, comprising a substantially tubular base body with a longitudinal axis, a baffle cap axially connected to the base body at a first end of the diffusor and a connecting device configured at a second end of the diffusor opposite to the first end. At least one outflow opening is formed in an outer wall of the tubular base body such that gas can flow out of an interior of the diffusor substantially in parallel to a longitudinal axis in the direction of the first end and the second end from the diffusor. The baffle cap is free from an outflow opening. The disclosure further relates to a gas generator comprising such a diffusor, as well as an airbag module including such a gas generator. Moreover, a method for manufacturing the diffusor is also proved.

Abstract: A nebulizer for nebulizing a liquid includes: a container containing multiple doses of the liquid, a housing part for receiving the container, where the container is moveable in an axial stroke within the housing part for withdrawing a dose of the liquid from the container and pressurizing the respective dose for nebulization; and an indicator device for counting or indicating a number of uses performed or still possible with the container, where the indicator device includes an indicator element and an actuator for actuating and/or stepwise moving the indicator element directly, and where the indicator element is rotatably and inseparately connected to the container or a casing (20) thereof and configured to move axially together with the container, and the actuator is rigidly connected to the housing part.

Abstract: In an assembly group comprising a cap of a tubular gas generator and a deflector element that deflects gas flowing out of at least one outflow opening of the cap to at least one discharge opening of the deflector element, a deflection surface of the deflector element is arranged radially outwardly of the outflow opening. At least two securing arms of the deflector element extend through the outflow opening and engage behind an edge defining the outflow opening on an inside in a positive connection with the cap. The cap is fixed firmly to an axial end of the tubular gas generator. Subsequently, the deflector element is slid from an outside of the cap with its securing arms through the outflow opening, the securing arms forming a positive connection with the edge of the outflow opening which fixes the deflector element firmly to the cap.

Abstract: This invention relates to methods employing IL-1 beta-ligand/IL-1 receptor disrupting compounds, such as IL-1 beta antibodies or IL-1 receptor antibodies, in the treatment and/or prevention of auto-inflammatory syndromes in mammals, particularly humans.

Abstract: According to one aspect, the present disclosure relates to a curable precursor of a structural adhesive composition, comprising: a) a thermally curable resin; b) a thermal curing initiator for the thermally curable resin; c) a radiation self-polymerizable multi-functional compound comprising a polyether oligomeric backbone and at least one free-radical (co)polymerizable reactive group at each terminal position of the oligomer backbone; and d) a free-radical polymerization initiator for the radiation self-polymerizable multi-functional compound; wherein the free-radical polymerization initiator is activated by visible light.

Abstract: Methods, systems, and computer readable media can be operable to facilitate an improved positioning of one of more LEDs on a device. A CPE (customer premise equipment) device may include a three-component subassembly composed of an LED module, light tube, and lightguide to allow for uniform lighting with design flexibility. The modularity of the design allows for decoupling from the PCB and reduces the design constraints.

Abstract: A suspension device for a backrest for assisting an adjustment movement may have at least one spring element with a basic body and two end portions protruding from the basic body. The device also having a bearing element with a guide opening, and a counterbearing element with a receptacle. A first end portion is arranged in the receptacle and is mounted movably in a first direction relative to the counterbearing element. A second end portion may be arranged in the guide opening and may be mounted movably in a second direction relative to the bearing element. A backrest and a seat arrangement having the suspension device are also provided.

Abstract: Surface supported quantum wells with a confined surface state capture and stably confine neutral atoms and molecules in a nanometer precise environment. Depending on the physico-chemical conditions in the capturing process, the degree of occupancy, the temperature of the solid substrate, and/or the history of external stimuli like electromagnetic field pulses, these atoms, molecules or clusters assume unique configurations. The atoms or molecules are able to remain coupled to the quantum-well specific electronic state in the confinement and as such exhibit local and delocalized quantum entanglement. The capturing potential arises from the superposition of Pauli repulsion between the captured object and the quantum well-specific confined electronic state. This occurs within on-surface atomic or supramolecular assemblies or surface supported coordination or covalent networks.

Abstract: The present invention relates to a measuring device with a magnetic field sensor for detecting at least one operating parameter of an agricultural joint shaft for torque transmission between a power take-off shaft of a towing vehicle and a transmission of an agricultural appliance, which includes at least one journal cross, to the opposing journals of which a shaft body is connected, and a protective tube rotatably accommodating the shaft body therein, wherein the magnetic field sensor is adapted to measure a magnetic field emanating from the bare shaft body of the joint shaft.

Abstract: A hybrid drive device includes an internal combustion engine, an electric machine and an impulse start module which comprises two clutches and a flywheel mass. A method for operating the hybrid device includes opening the first clutch of the impulse-start module and establishing a start-up requirement for the internal-combustion engine. The method also includes closing the first clutch with the second clutch in an open or closed position for a start of the internal-combustion engine.

Abstract: A hybrid drive transmission unit for a vehicle with an internal combustion engine and an electric motor for the drive part, includes a power-split transmission with sub-transmissions and a torsion-damping unit with a gyrating mass interconnected between the internal combustion engine and the power-split transmission. A clutch is interconnected between the internal combustion engine and the torsion-damping unit, by which the internal combustion engine can be activated, switching from the electromotive operating mode.

Abstract: The invention relates to methods for treating autoimmune inner ear disease (AIED). In particular, the invention relates to treating AIED with humanized anti-IL-1? antibodies or fragments thereof, especially monovalent, highly potent anti-IL-1? antibody fragments. The invention further relates to antibodies, compositions and kits for use in the methods of the invention.

Abstract: The invention relates to an ultrasonic sensor (112) for use in a distance detection system (110) for a vehicle (111), wherein the ultrasonic sensor (112) is designed to be installed jointly with at least one other ultrasonic sensor (112), the ultrasonic sensor (112) has a first input (114) for connection to a supply lead (116), the ultrasonic sensor (112) has a second input (118) for connection to a ground potential (120) of the vehicle (111), and the ultrasonic sensor (112) has an output (122) for connection to the supply lead (116), wherein the ultrasonic sensor (112) is designed to receive a data signal modulated on the supply lead (116) via the first input (114) and to modulate a data signal onto the supply lead (116) via the output (122).

Abstract: This invention relates to a novel use of IL-1?-ligand/IL-1 receptor disrupting compounds (herein referred to as “IL-1beta Compounds”); such as small molecular compounds disrupting IL-1b ligand-IL-1 receptor interaction, IL-1b antibodies or IL-1 receptor antibodies, e.g. IL-1b binding molecules described herein, e.g. antibodies disclosed herein, e.g. IL-1b binding compounds or IL-1 receptor binding compounds, and/or RNA compounds decreasing either IL-1b ligands or IL-1 receptor protein levels, in the treatment and/or prevention of auto-inflammatory syndromes, e.g. Juvenile rheumatoid arthritis or adult rheumatoid arthritis syndrome and to methods of treating and/or preventing auto-inflammatory syndromes, e.g. Juvenile rheumatoid arthritis or adult rheumatoid arthritis syndrome, in mammals, particularly humans.

Abstract: This invention relates to methods employing IL-1 beta-ligand/IL-1 receptor disrupting compounds, such as IL-1 beta antibodies or IL-1 receptor antibodies, in the treatment and/or prevention of auto-inflammatory syndromes in mammals, particularly humans.

Abstract: This invention relates to a novel use of IL-1?-ligand/IL-1 receptor disrupting compounds (herein referred to as “IL-1beta Compounds”); such as small molecular compounds disrupting IL-1b ligand-IL-1 receptor interaction, IL-1b antibodies or IL-1 receptor antibodies, e.g. IL-1b binding molecules described herein, e.g. antibodies disclosed herein, e.g. IL-1b binding compounds or IL-1 receptor binding compounds, and/or RNA compounds decreasing either IL-1b ligands or IL-1 receptor protein levels, in the treatment and/or prevention of auto-inflammatory syndromes, e.g. Juvenile rheumatoid arthritis or adult rheumatoid arthritis syndrome and to methods of treating and/or preventing auto-inflammatory syndromes, e.g. Juvenile rheumatoid arthritis or adult rheumatoid arthritis syndrome, in mammals, particularly humans.